Cardiovascular disease incidence rates: a study using routinely collected health data.
Ramroth J. et al, (2023), Cardiooncology, 9
Proton Beam Therapy for Early Breast Cancer: A Systematic Review and Meta-analysis of Clinical Outcomes.
Holt F. et al, (2023), Int J Radiat Oncol Biol Phys, 117, 869 - 882
Ki67 and breast cancer mortality in women with invasive breast cancer.
Probert J. et al, (2023), JNCI Cancer Spectr, 7
Temporal trends in the incidence of malignant and nonmalignant primary brain and central nervous system tumors by the method of diagnosis in England, 1993-2017.
Ali UM. et al, (2023), Neuro Oncol, 25, 1177 - 1192
Association of Radiation and Procarbazine Dose With Risk of Colorectal Cancer Among Survivors of Hodgkin Lymphoma.
Geurts YM. et al, (2023), JAMA Oncol, 9, 481 - 489
Exposure of the heart and cardiac valves in women irradiated for breast cancer 1970-2009.
Duane FK. et al, (2022), Clin Transl Radiat Oncol, 36, 132 - 139
Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortality.
Kerr AJ. et al, (2022), Cancer Treat Rev, 105
Proton Therapy in Supradiaphragmatic Lymphoma: Predicting Treatment-Related Mortality to Help Optimize Patient Selection.
Ntentas G. et al, (2022), Int J Radiat Oncol Biol Phys, 112, 913 - 925
Data Resource Profile: The Virtual Cardio-Oncology Research Initiative (VICORI) linking national English cancer registration and cardiovascular audits.
Sweeting MJ. et al, (2022), Int J Epidemiol, 50, 1768 - 1779
Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography-Directed Therapy for Early-Stage Hodgkin Lymphoma.
Cutter DJ. et al, (2021), J Clin Oncol, 39, 3591 - 3601
Exposure of the oesophagus in breast cancer radiotherapy: A systematic review of oesophagus doses published 2010-2020.
Duane FK. et al, (2021), Radiother Oncol, 164, 261 - 267
Oesophagus exposure in breast cancer radiotherapy: systematic review of oesophageal doses 2010-2020
Duane F. et al, (2021), RADIOTHERAPY AND ONCOLOGY, 161, S937 - S937
Dose-response relationships for radiation-related heart disease: Impact of uncertainties in cardiac dose reconstruction.
Ntentas G. et al, (2020), Radiother Oncol, 153, 155 - 162
Cardiac mortality after radiotherapy, chemotherapy and endocrine therapy for breast cancer: Cohort study of 2 million women from 57 cancer registries in 22 countries.
Henson KE. et al, (2020), Int J Cancer, 147, 1437 - 1449
Eligibility for Partial Breast Radiotherapy in England.
Taylor CW. et al, (2020), Clin Oncol (R Coll Radiol), 32, 217 - 220
Heart failure after treatment for breast cancer.
Boekel NB. et al, (2020), Eur J Heart Fail, 22, 366 - 374
An Excess Mortality Risk Analysis of Proton Beam versus Optimal Photon Radiotherapy for Mediastinal Hodgkin Lymphoma: Who May Benefit Most?
Ntentas G. et al, (2020), INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 108, S140 - S141
The Potential of the Primary Care Prescription Database to Verify Hormonal Therapy Use in Breast Cancer
Horgan K. et al, (2020), BREAST CANCER RESEARCH AND TREATMENT, 180, 589 - 589